Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Related structures:
AlphaFold database: A4HEM1
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 19 |
GO:0016787 | hydrolase activity | 2 | 19 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 19 |
GO:0016791 | phosphatase activity | 5 | 19 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 19 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 168 | 170 | PF00675 | 0.432 |
CLV_NRD_NRD_1 | 225 | 227 | PF00675 | 0.408 |
CLV_NRD_NRD_1 | 69 | 71 | PF00675 | 0.572 |
CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.348 |
CLV_PCSK_KEX2_1 | 168 | 170 | PF00082 | 0.411 |
CLV_PCSK_KEX2_1 | 225 | 227 | PF00082 | 0.408 |
CLV_PCSK_KEX2_1 | 69 | 71 | PF00082 | 0.607 |
CLV_PCSK_PC7_1 | 164 | 170 | PF00082 | 0.432 |
CLV_PCSK_SKI1_1 | 99 | 103 | PF00082 | 0.471 |
DOC_CYCLIN_yCln2_LP_2 | 101 | 104 | PF00134 | 0.487 |
DOC_MAPK_DCC_7 | 99 | 107 | PF00069 | 0.534 |
DOC_MAPK_gen_1 | 168 | 175 | PF00069 | 0.290 |
DOC_MAPK_gen_1 | 219 | 229 | PF00069 | 0.287 |
DOC_MAPK_MEF2A_6 | 112 | 119 | PF00069 | 0.273 |
DOC_MAPK_MEF2A_6 | 255 | 263 | PF00069 | 0.290 |
DOC_MAPK_MEF2A_6 | 99 | 107 | PF00069 | 0.451 |
DOC_MAPK_NFAT4_5 | 112 | 120 | PF00069 | 0.318 |
DOC_PP2B_LxvP_1 | 101 | 104 | PF13499 | 0.393 |
DOC_PP2B_LxvP_1 | 140 | 143 | PF13499 | 0.327 |
DOC_SPAK_OSR1_1 | 169 | 173 | PF12202 | 0.363 |
DOC_USP7_MATH_1 | 106 | 110 | PF00917 | 0.504 |
DOC_WW_Pin1_4 | 230 | 235 | PF00397 | 0.295 |
DOC_WW_Pin1_4 | 29 | 34 | PF00397 | 0.691 |
DOC_WW_Pin1_4 | 81 | 86 | PF00397 | 0.445 |
LIG_14-3-3_CanoR_1 | 147 | 152 | PF00244 | 0.164 |
LIG_14-3-3_CanoR_1 | 70 | 80 | PF00244 | 0.497 |
LIG_Actin_WH2_2 | 210 | 227 | PF00022 | 0.408 |
LIG_APCC_ABBA_1 | 199 | 204 | PF00400 | 0.317 |
LIG_APCC_ABBA_1 | 262 | 267 | PF00400 | 0.429 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.713 |
LIG_BRCT_BRCA1_1 | 166 | 170 | PF00533 | 0.408 |
LIG_EVH1_1 | 102 | 106 | PF00568 | 0.388 |
LIG_EVH1_2 | 103 | 107 | PF00568 | 0.419 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.289 |
LIG_FHA_1 | 148 | 154 | PF00498 | 0.267 |
LIG_FHA_1 | 59 | 65 | PF00498 | 0.645 |
LIG_FHA_1 | 73 | 79 | PF00498 | 0.500 |
LIG_FHA_2 | 205 | 211 | PF00498 | 0.408 |
LIG_FHA_2 | 6 | 12 | PF00498 | 0.543 |
LIG_FHA_2 | 74 | 80 | PF00498 | 0.552 |
LIG_LIR_Gen_1 | 133 | 143 | PF02991 | 0.425 |
LIG_LIR_Gen_1 | 160 | 170 | PF02991 | 0.303 |
LIG_LIR_Gen_1 | 258 | 266 | PF02991 | 0.368 |
LIG_LIR_Gen_1 | 274 | 284 | PF02991 | 0.306 |
LIG_LIR_Nem_3 | 133 | 139 | PF02991 | 0.379 |
LIG_LIR_Nem_3 | 152 | 158 | PF02991 | 0.125 |
LIG_LIR_Nem_3 | 160 | 165 | PF02991 | 0.259 |
LIG_LIR_Nem_3 | 167 | 173 | PF02991 | 0.234 |
LIG_LIR_Nem_3 | 258 | 263 | PF02991 | 0.368 |
LIG_LIR_Nem_3 | 274 | 279 | PF02991 | 0.310 |
LIG_MAD2 | 226 | 234 | PF02301 | 0.290 |
LIG_MYND_1 | 100 | 104 | PF01753 | 0.430 |
LIG_PCNA_TLS_4 | 156 | 163 | PF02747 | 0.408 |
LIG_PDZ_Class_3 | 285 | 290 | PF00595 | 0.461 |
LIG_REV1ctd_RIR_1 | 13 | 21 | PF16727 | 0.537 |
LIG_SH2_CRK | 136 | 140 | PF00017 | 0.342 |
LIG_SH2_STAP1 | 136 | 140 | PF00017 | 0.363 |
LIG_SH2_STAP1 | 149 | 153 | PF00017 | 0.363 |
LIG_SH2_STAT3 | 237 | 240 | PF00017 | 0.305 |
LIG_SH2_STAT5 | 149 | 152 | PF00017 | 0.310 |
LIG_SH2_STAT5 | 158 | 161 | PF00017 | 0.298 |
LIG_SH2_STAT5 | 182 | 185 | PF00017 | 0.317 |
LIG_SH2_STAT5 | 213 | 216 | PF00017 | 0.305 |
LIG_SH3_3 | 53 | 59 | PF00018 | 0.586 |
LIG_SH3_3 | 97 | 103 | PF00018 | 0.411 |
LIG_SH3_4 | 6 | 13 | PF00018 | 0.613 |
LIG_SUMO_SIM_anti_2 | 73 | 82 | PF11976 | 0.566 |
LIG_SUMO_SIM_par_1 | 113 | 118 | PF11976 | 0.303 |
LIG_SUMO_SIM_par_1 | 226 | 231 | PF11976 | 0.333 |
LIG_TRAF2_1 | 8 | 11 | PF00917 | 0.621 |
LIG_TRFH_1 | 260 | 264 | PF08558 | 0.408 |
LIG_TYR_ITIM | 134 | 139 | PF00017 | 0.408 |
LIG_WRPW_2 | 155 | 158 | PF00400 | 0.330 |
LIG_WW_2 | 103 | 106 | PF00397 | 0.405 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.665 |
MOD_CK1_1 | 274 | 280 | PF00069 | 0.327 |
MOD_CK1_1 | 34 | 40 | PF00069 | 0.658 |
MOD_CK1_1 | 71 | 77 | PF00069 | 0.576 |
MOD_CK2_1 | 204 | 210 | PF00069 | 0.441 |
MOD_CK2_1 | 5 | 11 | PF00069 | 0.573 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.695 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.680 |
MOD_GlcNHglycan | 70 | 73 | PF01048 | 0.441 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.319 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.560 |
MOD_GSK3_1 | 267 | 274 | PF00069 | 0.250 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.566 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.502 |
MOD_N-GLC_1 | 38 | 43 | PF02516 | 0.619 |
MOD_N-GLC_1 | 86 | 91 | PF02516 | 0.364 |
MOD_NEK2_1 | 123 | 128 | PF00069 | 0.327 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.313 |
MOD_NEK2_1 | 265 | 270 | PF00069 | 0.393 |
MOD_NEK2_1 | 271 | 276 | PF00069 | 0.422 |
MOD_NEK2_2 | 149 | 154 | PF00069 | 0.367 |
MOD_PIKK_1 | 31 | 37 | PF00454 | 0.691 |
MOD_PIKK_1 | 45 | 51 | PF00454 | 0.424 |
MOD_PIKK_1 | 6 | 12 | PF00454 | 0.615 |
MOD_PKA_2 | 68 | 74 | PF00069 | 0.670 |
MOD_Plk_1 | 119 | 125 | PF00069 | 0.305 |
MOD_Plk_1 | 209 | 215 | PF00069 | 0.315 |
MOD_Plk_2-3 | 204 | 210 | PF00069 | 0.408 |
MOD_Plk_4 | 111 | 117 | PF00069 | 0.326 |
MOD_Plk_4 | 119 | 125 | PF00069 | 0.309 |
MOD_Plk_4 | 246 | 252 | PF00069 | 0.334 |
MOD_Plk_4 | 271 | 277 | PF00069 | 0.322 |
MOD_ProDKin_1 | 230 | 236 | PF00069 | 0.295 |
MOD_ProDKin_1 | 29 | 35 | PF00069 | 0.692 |
MOD_ProDKin_1 | 81 | 87 | PF00069 | 0.436 |
TRG_AP2beta_CARGO_1 | 160 | 169 | PF09066 | 0.408 |
TRG_DiLeu_BaLyEn_6 | 97 | 102 | PF01217 | 0.476 |
TRG_ENDOCYTIC_2 | 136 | 139 | PF00928 | 0.349 |
TRG_ENDOCYTIC_2 | 276 | 279 | PF00928 | 0.341 |
TRG_ER_diArg_1 | 168 | 170 | PF00400 | 0.435 |
TRG_ER_diArg_1 | 224 | 226 | PF00400 | 0.408 |
TRG_NES_CRM1_1 | 44 | 58 | PF08389 | 0.520 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7Z9 | Leptomonas seymouri | 27% | 100% |
A0A0N1HTD7 | Leptomonas seymouri | 72% | 100% |
A0A0N1PG96 | Leptomonas seymouri | 53% | 82% |
A0A0S4IJH3 | Bodo saltans | 42% | 100% |
A0A0S4IMS1 | Bodo saltans | 45% | 86% |
A0A0S4JIG1 | Bodo saltans | 43% | 79% |
A0A1X0NYI7 | Trypanosomatidae | 51% | 72% |
A0A3Q8IDG4 | Leishmania donovani | 50% | 79% |
A0A3S7WY63 | Leishmania donovani | 28% | 100% |
A0A3S7WZH2 | Leishmania donovani | 88% | 100% |
A0A3S7X8P8 | Leishmania donovani | 29% | 100% |
A0A422P4K3 | Trypanosoma rangeli | 47% | 71% |
A4HEA5 | Leishmania braziliensis | 50% | 79% |
A4HM58 | Leishmania braziliensis | 29% | 100% |
A4I1Q1 | Leishmania infantum | 50% | 79% |
A4I1V3 | Leishmania infantum | 88% | 100% |
A4IAS0 | Leishmania infantum | 29% | 100% |
C9ZKA3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 69% |
E9AEA2 | Leishmania major | 28% | 100% |
E9AEJ6 | Leishmania major | 29% | 100% |
E9AH40 | Leishmania infantum | 28% | 100% |
E9AWL8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9AXT5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 50% | 79% |
E9AXZ7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
E9B5Q7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
O14595 | Homo sapiens | 36% | 100% |
Q20432 | Caenorhabditis elegans | 39% | 100% |
Q4Q077 | Leishmania major | 27% | 100% |
Q4Q9H6 | Leishmania major | 89% | 100% |
Q4Q9N6 | Leishmania major | 50% | 80% |
Q4QAV2 | Leishmania major | 28% | 100% |
Q61C05 | Caenorhabditis briggsae | 40% | 100% |
Q9W0S3 | Drosophila melanogaster | 30% | 71% |
V5B4L5 | Trypanosoma cruzi | 28% | 85% |